Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Hélène, Schroeder"'
Publikováno v:
Current Oncology, Vol 29, Iss 6, Pp 4178-4184 (2022)
PARP inhibitors, such as rucaparib, have been well characterized in metastatic castration-resistant prostate cancer (mCRPC) associated with BRCA alterations, and the clinical activity of these agents has also been evaluated in patients with mCRPC ass
Externí odkaz:
https://doaj.org/article/c16696233a7a45dda11691fcfdfe6d10
Autor:
Concetta Elisa Onesti, Hélène Schroeder, Andrée Rorive, Brieuc Sautois, Marie Lecocq, Marie Goffin, Elodie Gonne, Astrid Collinge, Laurence Nicolaers, Odile Wéra, Amandine Catot, Catherine Loly, Astrid Paulus, Anne Sibille, Laurence Lousberg, Florence Troisfontaine, Joëlle Collignon, Christine Gennigens, Pierre Frères, Marc Polus, Bernard Duysinx, Frédérique Vaillant, Nathalie Marchal, Aurélie Poncin, Guy Jerusalem
Publikováno v:
Cancer Reports, Vol 5, Iss 10, Pp n/a-n/a (2022)
Abstract Background The spread of the COVID‐19 pandemic has led to a rapid reorganization in all human and hospital activities, with impact on cancer patients. Aim An analysis of cancer patients fears, and awareness of COVID‐19 has been done in t
Externí odkaz:
https://doaj.org/article/4801fa676c274876a0c7ba8b5957c880
Autor:
Christine Gilles, Myriam Polette, Cécile Oury, Agnès Noël, Brett G. Hollier, Silvia Blacher, Marc Thiry, Geert Berx, Guy Jérusalem, Erik W. Thompson, Nicolas Skrypek, Céline Delierneux, Hélène Schroeder, Marie-Emilie Francart, Justine Lambert, Meggy Suarez-Carmona, Morgane Bourcy
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74ad028f330b19adb7a33964d96a6229
https://doi.org/10.1158/0008-5472.22409385.v1
https://doi.org/10.1158/0008-5472.22409385.v1
Autor:
Christine Gilles, Myriam Polette, Cécile Oury, Agnès Noël, Brett G. Hollier, Silvia Blacher, Marc Thiry, Geert Berx, Guy Jérusalem, Erik W. Thompson, Nicolas Skrypek, Céline Delierneux, Hélène Schroeder, Marie-Emilie Francart, Justine Lambert, Meggy Suarez-Carmona, Morgane Bourcy
Supplementary Table 1: list of siRNA used. Supplementary Table 2: list of primers used. Supplementary Table 3: list of antibodies used in different applications. Supplementary Table 4: list of patients and donors information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::925c54b710e1129d49e6b0806d88c6f7
https://doi.org/10.1158/0008-5472.22409382
https://doi.org/10.1158/0008-5472.22409382
Autor:
Christine Gilles, Myriam Polette, Cécile Oury, Agnès Noël, Brett G. Hollier, Silvia Blacher, Marc Thiry, Geert Berx, Guy Jérusalem, Erik W. Thompson, Nicolas Skrypek, Céline Delierneux, Hélène Schroeder, Marie-Emilie Francart, Justine Lambert, Meggy Suarez-Carmona, Morgane Bourcy
Epithelial–mesenchymal transition (EMT) is prominent in circulating tumor cells (CTC), but how it influences metastatic spread in this setting is obscure. Insofar as blood provides a specific microenvironment for tumor cells, we explored a potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16375b758c2ee55a710ccc2bb23973f9
https://doi.org/10.1158/0008-5472.c.6507768
https://doi.org/10.1158/0008-5472.c.6507768
Autor:
Christine Gilles, Myriam Polette, Cécile Oury, Agnès Noël, Brett G. Hollier, Silvia Blacher, Marc Thiry, Geert Berx, Guy Jérusalem, Erik W. Thompson, Nicolas Skrypek, Céline Delierneux, Hélène Schroeder, Marie-Emilie Francart, Justine Lambert, Meggy Suarez-Carmona, Morgane Bourcy
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7761cec11b3411bafb63a618a7887453
https://doi.org/10.1158/0008-5472.22409394
https://doi.org/10.1158/0008-5472.22409394
Autor:
Concetta Elisa, Onesti, Hélène, Schroeder, Andrée, Rorive, Brieuc, Sautois, Marie, Lecocq, Marie, Goffin, Elodie, Gonne, Astrid, Collinge, Laurence, Nicolaers, Odile, Wéra, Amandine, Catot, Catherine, Loly, Astrid, Paulus, Anne, Sibille, Laurence, Lousberg, Florence, Troisfontaine, Joëlle, Collignon, Christine, Gennigens, Pierre, Frères, Marc, Polus, Bernard, Duysinx, Frédérique, Vaillant, Nathalie, Marchal, Aurélie, Poncin, Guy, Jerusalem
Publikováno v:
Cancer Reports
Background The spread of the COVID‐19 pandemic has led to a rapid reorganization in all human and hospital activities, with impact on cancer patients. Aim An analysis of cancer patients fears, and awareness of COVID‐19 has been done in this study
Autor:
Nathalie Marchal, Marie Goffin, Marie Lecocq, Amandine Catot, Concetta Elisa Onesti, Elodie Gonne, Odile Wera, Laurence Nicolaers, Aurélie Poncin, Joëlle Collignon, Andrée Rorive, Christine Gennigens, Bernard Duysinx, Guy Jerusalem, Hélène Schroeder, Pierre Frères, F Vaillant, Marc Polus, Brieuc Sautois, Astrid Collinge
Publikováno v:
Annals of Oncology
Background: No specific safety data concerning systemic oncological treatments were available at time of COVID-19 outbreak in Belgium. In our hospital we decided to maintain adjuvant and early line treatments for metastatic disease in patients under
Autor:
Joëlle Collignon, Corinne Fasquelle, Latifa Karim, Meriem Boukerroucha, Vincent Bours, Jean-Hubert Caberg, Claire Josse, Benoit Hennuy, Veronique Jossa, Fabrice Olivier, Hélène Schroeder, Warda Bezzaou, Guy Jerusalem, Sonia ElGuendi, Benoit Charloteaux, Pierre Frères, Stephane Wenric
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Scientific Reports
Scientific Reports
Non-coding RNAs (ncRNA) represent 1/5 of the mammalian transcript number, and 90% of the genome length is transcribed. Many ncRNAs play a role in cancer. Among them, non-coding natural antisense transcripts (ncNAT) are RNA sequences that are compleme
Autor:
Philippe Delvenne, Nor Eddine Sounni, Mehdi Lienard, Joan Somja, Stéphanie Gofflot, Agnès Noël, Joëlle Collignon, Guy Jerusalem, Anne-Françoise Donneau, Pierre Foidart, Hélène Schroeder, Emilie Feyereisen, Cassandre Yip, Alice Truong
Publikováno v:
British Journal of Cancer
Background: Triple-negative breast cancers (TNBC) are heterogeneous cancers with poor prognosis. We aimed to determine the clinical relevance of membrane type-4 matrix metalloproteinase (MT4-MMP), a membrane type matrix metalloproteinase that interac